Risk of drug-induced pericardial effusion: a disproportionality analysis of the FAERS database
This study systematically compiled a list of drugs with potential risks of causing pericardial effusion. There is a significant association between pericardial effusion and the use of hydralazine, dasatinib, and mesalazine. Moreover, pericardial effusion is more common in patient groups receiving treatments with antineoplastic and immunomodulating agents.
Authors
- Yanqiu Ding
- Gaocan Ren
- Xiaochang Ma
- Pingping Huang (ORCID: https://orcid.org/0000-0003-0191-2610)
Institutions
- Beijing University of Chinese Medicine (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Xiyuan Hospital (CN)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1186/s40360-025-00867-6
- Citations
- 5
- Primary Topic
- Pericarditis and Cardiac Tamponade
- Type
- article
- Field-Weighted Citation Impact
- 6.94
Funders
- National Natural Science Foundation of China
- China Academy of Chinese Medical Sciences